{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:13:06Z","timestamp":1780686786340,"version":"3.54.1"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.01145","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T06:30:18Z","timestamp":1572935418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets"],"prefix":"10.3389","volume":"9","author":[{"given":"Maria Sofia","family":"Basile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fagone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fallico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Bonfiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresio","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.21873\/anticanres.12110","article-title":"Clinical, histopathological and cytogenetic prognosticators in uveal melanoma - A comprehensive review","volume":"37","author":"Berus","year":"2017","journal-title":"Anticancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1101\/gad.296962.117","article-title":"Focus on cutaneous and uveal melanoma specificities","volume":"31","author":"Pandiani","year":"2017","journal-title":"Genes Dev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"360136","DOI":"10.1155\/2010\/360136","article-title":"Genetics of uveal melanoma and cutaneous melanoma: two of a kind?","volume":"2010","author":"van den Bosch","year":"2010","journal-title":"Dermatol Res Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/S0923-1811(98)83846-2","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00008390-200310000-00007","article-title":"Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes","volume":"13","author":"Pirker","year":"2003","journal-title":"Melanoma Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0138002","DOI":"10.1371\/journal.pone.0138002","article-title":"Distribution of GNAQ and GNA11 mutation signatures in uveal melanoma points to a light dependent mutation mechanism","volume":"10","author":"de Lange","year":"2015","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0116371","DOI":"10.1371\/journal.pone.0116371","article-title":"Digital PCR validates 8q dosage as prognostic tool in uveal melanoma","volume":"10","author":"Versluis","year":"2015","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0178189","DOI":"10.1371\/journal.pone.0178189","article-title":"Systematic genomic and translational efficiency studies of uveal melanoma","volume":"12","author":"Johnson","year":"2017","journal-title":"PLoS ONE"},{"key":"B10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1158\/2159-8290.CD-17-1418","article-title":"Combined analysis of antigen presentation and T-cell recognition reveals restricted immune responses in melanoma","volume":"8","author":"Kalaora","year":"2018","journal-title":"Cancer Discov"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aad1253","article-title":"Immunogenicity of somatic mutations in human gastrointestinal cancers","volume":"350","author":"Tran","year":"2015","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2012.00148","article-title":"Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism?","volume":"3","author":"Niederkorn","year":"2012","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.preteyeres.2018.12.002","article-title":"Immune cells in the retina and choroid: two different tissue environments that require different defenses and surveillance","volume":"70","author":"McMenamin","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fimmu.2012.00338","article-title":"Good news-bad news: the Yin and Yang of immune privilege in the eye","volume":"3","author":"Forrester","year":"2012","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2012.00303","article-title":"Influence of CD8+ T regulatory cells on intraocular tumor development","volume":"3","author":"McKenna","year":"2012","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow \u2013 A review","volume":"88","author":"Alm","year":"2009","journal-title":"Exp Eye Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1076\/ceyr.16.9.900.5043","article-title":"Aqueous humor induces transforming growth factor-beta (TGF-beta)-producing regulatory T-cells","volume":"16","author":"Taylor","year":"1997","journal-title":"Curr Eye Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1365-2249.1998.00604.x","article-title":"Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)","volume":"113","author":"Nicoletti","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.intimp.2017.01.019","article-title":"TGF-\u03b2 engineered mesenchymal stem cells (TGF-\u03b2\/MSCs) for treatment of Type 1 diabetes (T1D) mice model","volume":"44","author":"Daneshmandi","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29108","article-title":"Transforming growth factor \u03b2 signaling pathway: a promising therapeutic target for cancer","author":"Chen","year":"2019","journal-title":"J Cell Physiol"},{"key":"B24","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.160.12.5693","article-title":"Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege","volume":"160","author":"Apte","year":"1998","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneuroim.2018.06.009","article-title":"Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: in silico and in vivo evidences","volume":"322","author":"Fagone","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","article-title":"Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barr\u00e9 syndrome and experimental allergic neuritis","volume":"168","author":"Nicoletti","year":"2005","journal-title":"J Neuroimmunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3892\/ol.2018.8990","article-title":"Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma","volume":"16","author":"Presti","year":"2018","journal-title":"Oncol Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/cancers11040529","article-title":"Role of macrophage migration inhibitory factor (MIF) in melanoma","volume":"11","author":"Soumoy","year":"2019","journal-title":"Cancers"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/hed.24939","article-title":"Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: a systematic review","volume":"39","author":"Lechien","year":"2017","journal-title":"Head Neck"},{"key":"B30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/1471-2407-14-630","article-title":"Macrophage migration inhibitory factor engages PI3K\/Akt signalling and is a prognostic factor in metastatic melanoma","volume":"14","author":"Oliveira","year":"2014","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4049\/jimmunol.156.8.2667","article-title":"Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye","volume":"156","author":"Apte","year":"1996","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S0002-9394(14)70856-6","article-title":"Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors","volume":"38","author":"Apte","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","first-page":"811","article-title":"Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact","volume":"41","author":"Yoshida","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1167\/iovs.05-1041","article-title":"Antigen from the anterior chamber of the eye travels in a soluble form to secondary lymphoid organs via lymphatic and vascular routes","volume":"47","author":"Camelo","year":"2006","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.4049\/jimmunol.172.9.5388","article-title":"The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye","volume":"172","author":"Camelo","year":"2004","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1679197","DOI":"10.1155\/2018\/1679197","article-title":"Immune privilege and eye-derived T-regulatory cells","volume":"2018","author":"Keino","year":"2018","journal-title":"J Immunol Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-018-0644-y","article-title":"Targeting the IDO1 pathway in cancer: from bench to bedside","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"17951","DOI":"10.18632\/oncotarget.24885","article-title":"Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach","volume":"9","author":"Mangano","year":"2018","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.drudis.2015.07.003","article-title":"Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies","volume":"20","author":"Borch","year":"2015","journal-title":"Drug Discov Today"},{"key":"B40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/path.926","article-title":"Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value","volume":"194","author":"Anastassiou","year":"2001","journal-title":"J Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/1097-0142(19900101)65:1<112::AID-CNCR2820650123>3.0.CO;2-X","article-title":"Lymphocytic infiltration in uveal malignant melanoma","volume":"65","author":"de la Cruz","year":"1990","journal-title":"Cancer"},{"key":"B42","first-page":"1414","article-title":"Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma","volume":"42","author":"M\u00e4kitie","year":"2001","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/eye.1990.41","article-title":"Permeability of ocular vessels and transport across the blood-retinal-barrier","volume":"4","author":"T\u00f6rnquist","year":"1990","journal-title":"Eye"},{"key":"B44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/978-1-4614-4711-5_3","article-title":"The blood-retina barrier: tight junctions and barrier modulation","volume":"763","author":"Campbell","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/00002371-199707000-00003","article-title":"Expression of MAGE genes in ocular melanoma cell lines","volume":"20","author":"Chen","year":"1997","journal-title":"J Immunother"},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00008390-199802000-00003","article-title":"Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines","volume":"8","author":"Luyten","year":"1998","journal-title":"Melanoma Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/(SICI)1097-0215(19960611)66:6<738::AID-IJC5>3.0.CO;2-0","article-title":"Infrequent expression of the MAGE gene family in uveal melanomas","volume":"66","author":"Mulcahy","year":"1996","journal-title":"Int J Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/BF01756599","article-title":"Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients","volume":"33","author":"Kan-Mitchell","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"B49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1076\/ceyr.17.2.165.5607","article-title":"Uveal melanomas contain antigenically specific and non-specific infiltrating lymphocytes","volume":"17","author":"Ksander","year":"1998","journal-title":"Curr Eye Res"},{"key":"B50","first-page":"3198","article-title":"Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma","volume":"32","author":"Ksander","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF01786881","article-title":"Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye","volume":"30","author":"Knisely","year":"1990","journal-title":"Cancer Immunol Immunother"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1167\/iovs.10-5526","article-title":"Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration","volume":"51","author":"Ly","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1167\/iovs.08-2733","article-title":"Evidence for natural killer cell\u2013mediated protection from metastasis formation in uveal melanoma patients","volume":"50","author":"Maat","year":"2009","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/sj.bjc.6602123","article-title":"Loss of nonclassical MHC molecules MIC-A\/B expression during progression of uveal melanoma","volume":"91","author":"Vetter","year":"2004","journal-title":"Br J Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1158\/0008-5472.CAN-04-0508","article-title":"Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes","volume":"64","author":"Hallermalm","year":"2004","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.4049\/jimmunol.136.10.3916","article-title":"Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness","volume":"136","author":"Rook","year":"1986","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1167\/iovs.04-0599","article-title":"Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells","volume":"45","author":"He","year":"2004","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.4049\/jimmunol.165.10.5502","article-title":"IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen","volume":"165","author":"Beatty","year":"2000","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9440(10)64871-7","article-title":"Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells","volume":"160","author":"Le Poole","year":"2002","journal-title":"Am J Pathol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1158\/1078-0432.CCR-15-2294","article-title":"Identification of an immunogenic subset of metastatic uveal melanoma","volume":"22","author":"Rothermel","year":"2016","journal-title":"Clin Cancer Res"},{"key":"B61","first-page":"223","article-title":"Infiltrative T regulatory cells in enucleated uveal melanomas","volume":"107","author":"Lagouros","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1002\/cncr.24999","article-title":"Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma","volume":"116","author":"Mougiakakos","year":"2010","journal-title":"Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molimm.2013.11.018","article-title":"Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease","volume":"58","author":"Achberger","year":"2014","journal-title":"Mol Immunol"},{"key":"B64","first-page":"2106","article-title":"Analysis of lymphocytic infiltration in uveal melanoma","volume":"31","author":"Durie","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B65","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.4049\/jimmunol.134.3.1381","article-title":"Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB\/c mice by P815 cells","volume":"134","author":"Streilein","year":"1985","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.4049\/jimmunol.177.3.1599","article-title":"Accumulation of immunosuppressive CD11b+ myeloid cells correlates with the failure to prevent tumor growth in the anterior chamber of the eye","volume":"177","author":"McKenna","year":"2006","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41467-018-04524-x","article-title":"Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node","volume":"9","author":"Alonso","year":"2018","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells","volume":"12","author":"Brandacher","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1746.2003.03259.x","article-title":"Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma","volume":"19","author":"Ishio","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","article-title":"Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer","volume":"95","author":"Ino","year":"2006","journal-title":"Br J Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000096906","article-title":"Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients","volume":"214","author":"Weinlich","year":"2007","journal-title":"Dermatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/eji.200535238","article-title":"Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression","volume":"36","author":"Beutelspacher","year":"2006","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1167\/iovs.05-1336","article-title":"Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor","volume":"48","author":"Ryu","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.exer.2007.07.014","article-title":"Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion","volume":"85","author":"Chen","year":"2007","journal-title":"Exp Eye Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1158\/1538-7445.AM2018-3805","article-title":"Abstract 3805: expression of tryptophan\u22122, 3-dioxygense (TDO) in metastatic uveal melanoma","volume":"78","author":"Terai","year":"2018","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1167\/iovs.07-0786","article-title":"Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma","volume":"49","author":"Maat","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1167\/iovs.07-1606","article-title":"PD-L1 expression by human uveal melanoma inhibits T-cell function","volume":"49","author":"Yang","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/labinvest.2017.64","article-title":"Melanoma subtypes demonstrate distinct PD-L1 expression profiles","volume":"97","author":"Kaunitz","year":"2017","journal-title":"Lab Invest."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0210276","DOI":"10.1371\/journal.pone.0210276","article-title":"Differential modulation and prognostic values of immune-escape genes in uveal melanoma","volume":"14","author":"Basile","year":"2019","journal-title":"PLoS ONE"},{"key":"B83","doi-asserted-by":"publisher","first-page":"609","DOI":"10.21037\/tcr.2018.05.31","article-title":"Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis","volume":"7","author":"Zhao","year":"2018","journal-title":"Transl Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imr.12527","article-title":"The CD47-SIRP\u03b1 signaling axis as an innate immune checkpoint in cancer","volume":"276","author":"Matlung","year":"2017","journal-title":"Immunol Rev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.3390\/molecules24132450","article-title":"Characterization of the pathophysiological role of CD47 in uveal melanoma","volume":"24","author":"Petralia","year":"2019","journal-title":"Molecules"},{"key":"B86","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1471-4906(02)02223-8","article-title":"CD200 and membrane protein interactions in the control of myeloid cells","volume":"23","author":"Barclay","year":"2002","journal-title":"Trends Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fphys.2018.00452","article-title":"Galectin-9 expression predicts favorable clinical outcome in solid tumors: a systematic review and meta-analysis","volume":"9","author":"Zhou","year":"2018","journal-title":"Front Physiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cca.2018.02.038","article-title":"Prognostic value of DcR3 in solid tumors: a meta-analysis","volume":"481","author":"Ge","year":"2018","journal-title":"Clin Chim Acta"},{"key":"B90","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fonc.2019.00696","article-title":"Hydrogen gas in cancer treatment","volume":"9","author":"Li","year":"2019","journal-title":"Front Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejphar.2018.07.026","article-title":"Gasotransmitters and the immune system: mode of action and novel therapeutic targets","volume":"834","author":"Fagone","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.1158\/0008-5472.CAN-04-2201","article-title":"Nitric oxide, a mediator of inflammation, suppresses tumorigenesis","volume":"64","author":"Hussain","year":"2004","journal-title":"Cancer Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.niox.2016.02.002","article-title":"Nitric oxide signaling in human ovarian cancer: a potential therapeutic target","volume":"54","author":"El-Sehemy","year":"2016","journal-title":"Nitric Oxide Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6304851","DOI":"10.1155\/2019\/6304851","article-title":"Prognostic value of inducible nitric oxide synthase (iNOS) in human cancer: a systematic review and meta-analysis","volume":"2019","author":"Liao","year":"2019","journal-title":"Biomed Res Int"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/ijc.24984","article-title":"Expression and prognostic significance of iNOS in uveal melanoma","volume":"126","author":"Johansson","year":"2010","journal-title":"Int J Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trsl.2019.03.003","article-title":"Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says \u201cNO\u201d to antitumor immune response","volume":"210","author":"Pe\u00d1arando","year":"2019","journal-title":"Transl Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40425-019-0698-6","article-title":"Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition","volume":"7","author":"Newton","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10637-019-00733-3","article-title":"Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo","volume":"37","author":"Paskas","year":"2019","journal-title":"Invest New Drugs."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3390\/molecules23102463","article-title":"Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells","volume":"23","author":"Basile","year":"2018","journal-title":"Molecules"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.leukres.2015.06.013","article-title":"The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: role of p70S6K","volume":"39","author":"Maksimovic-Ivanic","year":"2015","journal-title":"Leuk Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/mc.23020","article-title":"Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma","volume":"58","author":"Paska\u0161","year":"2019","journal-title":"Mol Carcinog"},{"key":"B102","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.02.040","article-title":"Nitric oxide donors for prostate and bladder cancers: current state and challenges","volume":"826","author":"Seabra","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/bjo.2008.145664","article-title":"CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation","volume":"93","author":"Holfort","year":"2009","journal-title":"Br J Ophthalmol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1167\/iovs.07-1035","article-title":"Differential expression of chemokine receptors on uveal melanoma cells and their metastases","volume":"49","author":"Li","year":"2008","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","first-page":"49623","DOI":"10.18632\/oncotarget.10418","article-title":"In-depth proteomic profiling of the uveal melanoma secretome","volume":"7","author":"Angi","year":"2016","journal-title":"Oncotarget"},{"key":"B107","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1158\/1078-0432.CCR-06-2630","article-title":"Molecular pathways mediating liver metastasis in patients with uveal melanoma","volume":"14","author":"Bakalian","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0016-5085(99)70508-1","article-title":"Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells","volume":"116","author":"Knolle","year":"1999","journal-title":"Gastroenterology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1053\/gast.1996.v110.pm8613007","article-title":"Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells","volume":"110","author":"Lohse","year":"1996","journal-title":"Gastroenterology"},{"key":"B110","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/hep.1840060505","article-title":"Phagocytosis, an unrecognized property of murine endothelial liver cells","volume":"6","author":"Steffan","year":"1986","journal-title":"Hepatology."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/hep.25844","article-title":"Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice","volume":"56","author":"H\u00f6chst","year":"2012","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2007","journal-title":"Hepatology"},{"key":"B113","doi-asserted-by":"publisher","first-page":"14097","DOI":"10.1073\/pnas.1617903113","article-title":"The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis","volume":"113","author":"Kimura","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B114","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00713.x","article-title":"IL-10 down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells through decreased antigen uptake via the mannose receptor and lowered surface expression of accessory molecules","volume":"114","author":"Knolle","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.it.2017.02.008","article-title":"Liver-resident NK cells: the human factor","volume":"38","author":"Male","year":"2017","journal-title":"Trends Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12885-019-5712-3","article-title":"Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma","volume":"19","author":"Jones","year":"2019","journal-title":"BMC Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ijc.29480","article-title":"NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases","volume":"137","author":"Sadegh","year":"2015","journal-title":"Int J Cancer"},{"key":"B119","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.humpath.2017.06.005","article-title":"Inflammatory cell infiltrates in advanced metastatic uveal melanoma","volume":"66","author":"Krishna","year":"2017","journal-title":"Hum Pathol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"44564","DOI":"10.1038\/srep44564","article-title":"Identification of novel chemotherapeutic strategies for metastatic uveal melanoma","volume":"7","author":"Fagone","year":"2017","journal-title":"Sci Rep"},{"key":"B121","doi-asserted-by":"publisher","first-page":"172","DOI":"10.21037\/atm.2016.05.04","article-title":"Uveal melanoma as a target for immune-therapy","volume":"4","author":"Oliva","year":"2016","journal-title":"Ann Transl Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1908065","DOI":"10.1155\/2018\/1908065","article-title":"Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma","volume":"2018","author":"Mignard","year":"2018","journal-title":"J Oncol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/cancers11020152","article-title":"Adjuvant ipilimumab in high-risk uveal melanoma","volume":"11","author":"Fountain","year":"2019","journal-title":"Cancers"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1002\/cncr.30258","article-title":"Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies","volume":"122","author":"Algazi","year":"2016","journal-title":"Cancer"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00262-019-02352-6","article-title":"Pembrolizumab as first-line treatment for metastatic uveal melanoma","volume":"68","author":"Rossi","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N Engl J Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"175883401875717","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1093\/annonc\/mdt376","article-title":"Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma","volume":"24","author":"Maio","year":"2013","journal-title":"Ann Oncol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"N Engl J Med"},{"key":"B130","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/CMR.0000000000000175","article-title":"A phase 2 study of tremelimumab in patients with advanced uveal melanoma","volume":"25","author":"Joshua","year":"2015","journal-title":"Melanoma Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"mdy289","DOI":"10.1093\/annonc\/mdy289.003","article-title":"Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)","volume":"29","author":"Piulats Rodriguez","year":"2018","journal-title":"Ann Oncol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/annonc\/mdy288","article-title":"Efficacy of racotumomab or nimotuzumab vs docetaxel as second-line therapy for advanced non-small cell lung cancer patients","volume":"29","author":"Hernandez","year":"2018","journal-title":"Ann Oncol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3560640","DOI":"10.1155\/2019\/3560640","article-title":"Nivolumab and ipilimumab in the treatment of metastatic uveal melanoma: a single-center experience","volume":"2019","author":"Karivedu","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jvir.2018.04.030","article-title":"Combined effects of yttrium-90 transarterial radioembolization around immunotherapy for hepatic metastases from uveal melanoma: a preliminary retrospective case series","volume":"29","author":"Zheng","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S1470-2045(17)30251-6","article-title":"Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study","volume":"18","author":"Chandran","year":"2017","journal-title":"Lancet Oncol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2217\/fon-2018-0116","article-title":"Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?","volume":"14","author":"Sacco","year":"2018","journal-title":"Future Oncol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40425-018-0322-1","article-title":"Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone","volume":"6","author":"Afzal","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B138","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.drudis.2018.11.003","article-title":"Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets","volume":"24","author":"G\u00fcnther","year":"2019","journal-title":"Drug Discov Today"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01145\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T13:42:50Z","timestamp":1695390170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.01145\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":139,"alternative-id":["10.3389\/fonc.2019.01145"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.01145","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"article-number":"1145"}}